Tag: Photrexa

Over 95% of commercially insured patients now have access to FDA-approved corneal cross-linking using Photrexa and the KXL system. In this outpatient procedure, a clinician administers the prescription riboflavin eye drops, or Photrexa, in a specific sequence to treat progressive keratoconus or corneal ectasia.

Keratoconus is a progressive eye disease where the cornea thins and weakens, a condition that can lead to severe vision loss and may require a corneal transplant in up to 20% of patients if left untreated [1.3.7]. A promising new treatment is emerging, which begs the question: **What is epioxa?**